NCT02767388View on ClinicalTrials.gov

Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

December 11, 2017

Study Completion Date

March 15, 2018

Conditions
Myelodysplastic SyndromeEffects of ChemotherapyMild Cognitive ImpairmentMultiple MyelomaNon-hodgkin LymphomaChronic Lymphocytic LeukemiaAcute Lymphoid LeukemiaChronic Myeloid LeukemiaAcute Myeloid Leukemia
Trial Locations (1)

68132

University of Nebraska Medical Center, Omaha

All Listed Sponsors
lead

University of Nebraska

OTHER

NCT02767388 - Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery | Biotech Hunter | Biotech Hunter